SYNGENE INTERNATIONAL
Back to Balance Sheet
|
SYNGENE INTERNATIONAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-41 Cr | ₹-70 Cr | ₹-66 Cr | ₹-89 Cr | ₹-123 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SYNGENE INTERNATIONAL ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-41 Cr |
Mar2023 | ₹-70 Cr |
Mar2022 | ₹-66 Cr |
Mar2021 | ₹-89 Cr |
Mar2020 | ₹-123 Cr |
How is Deferred Tax Assets / Liabilities of SYNGENE INTERNATIONAL Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-41 Cr | Negative | |
Mar2023 | ₹-70 Cr | Negative | |
Mar2022 | ₹-66 Cr | Negative | |
Mar2021 | ₹-89 Cr | Negative | |
Mar2020 | ₹-123 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SYNGENE INTERNATIONAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNGENE INTERNATIONAL | ₹28,072.4 Cr | -0.1% | 10.8% | 3.5% | Stock Analytics | |
SAGILITY INDIA | ₹18,023.1 Cr | -5.7% | -4.9% | NA | Stock Analytics | |
LATENT VIEW ANALYTICS | ₹7,297.7 Cr | -0.9% | -2.7% | -29.8% | Stock Analytics | |
JUST DIAL | ₹6,774.5 Cr | 0.9% | -0.1% | -3.1% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,635.8 Cr | -1.9% | 14.8% | -60.8% | Stock Analytics | |
AWFIS SPACE SOLUTIONS | ₹4,360.7 Cr | -2.8% | -1.9% | NA | Stock Analytics |
SYNGENE INTERNATIONAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNGENE INTERNATIONAL | -0.1% |
10.8% |
3.5% |
SENSEX | -5.5% |
0.2% |
-1% |
You may also like the below Video Courses